Recent Decision in FCA Case Has Key Implications for Labs
A January summary judgment has added to the split among courts when it comes to determining labs’ liability under the False Claims Act
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
A January summary judgment has added to the split among courts when it comes to determining labs’ liability under the False Claims Act
ACLA president Susan Van Meter discusses some of the key issues labs faced in 2024, along with work to address these developments through 2025
Regulatory expert Julie Ballard shares her thoughts on the most useful resources for labs as they get ready to comply with Stage 1
Sara Pirzadeh-Miller offers advice on overcoming the reimbursement barriers genetic counselors face in the clinical lab and beyond
Revenue cycle management leaders provide their thoughts on how lab leaders may want to proceed when it comes to POC tests
The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
With the rule recently struck down by a Texas court, how should employers, including labs, handle such agreements going forward?
A PT update went into effect on January 1, focusing on revised acceptance limits, among other modifications
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025